Your browser doesn't support javascript.
loading
Impact of Pre-Existing Bradycardia on Subsequent Need for Pacemaker Implantation After Radiofrequency Catheter Ablation for Atrial Fibrillation.
Kawaji, Tetsuma; Shizuta, Satoshi; Yamagami, Shintaro; Aizawa, Takanori; Yoshizawa, Takashi; Kato, Masashi; Yokomatsu, Takafumi; Miki, Shinji; Ono, Koh; Kimura, Takeshi.
Affiliation
  • Kawaji T; Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital.
  • Shizuta S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
  • Yamagami S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
  • Aizawa T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
  • Yoshizawa T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
  • Kato M; Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital.
  • Yokomatsu T; Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital.
  • Miki S; Department of Cardiovascular Medicine, Mitsubishi Kyoto Hospital.
  • Ono K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
  • Kimura T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
Circ J ; 82(10): 2493-2499, 2018 09 25.
Article in En | MEDLINE | ID: mdl-30058606
ABSTRACT

BACKGROUND:

The incidence of subsequent need for permanent pacemaker implantation (PMI) after radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) in real world patients with and without pre-existing bradycardia has not yet been fully evaluated. Methods and 

Results:

A total of 1,131 consecutive patients undergoing first-time RFCA for AF who had no previous or planned device implantation, were enrolled in the present study. Of 799 paroxysmal AF (PAF) patients, 121 (15.1%) had sinus node dysfunction (SND). Of 332 non-PAF patients, 73 (22.0%) had slow ventricular response (VR), defined as heart rate <80 beats/min at rest without any rate-control drugs. The 5-year cumulative incidence of PMI after RFCA in PAF patients with and without SND was 14.8% and 1.7%, respectively (P<0.001). The 5-year cumulative incidence of PMI after RFCA in non-PAF patients with and without slow VR was 14.8% and 4.7%, respectively (P<0.001). SND and female gender in PAF patients, as well as slow VR and age ≥75 years in non-PAF patients, were independent and additive predictors of PMI. The 5-year cumulative incidence of PMI was 26.3% in female PAF patients with SND and 33.3% in elderly non-PAF patients with slow VR.

CONCLUSIONS:

PMI was avoided in >85% of patients undergoing RFCA for PAF with pre-existing SND, although care should be taken for female patients. Decision-making regarding RFCA for non-PAF patients with slow VR, especially in the elderly, should be cautious.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pacemaker, Artificial / Atrial Fibrillation / Sick Sinus Syndrome / Bradycardia / Catheter Ablation Type of study: Incidence_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pacemaker, Artificial / Atrial Fibrillation / Sick Sinus Syndrome / Bradycardia / Catheter Ablation Type of study: Incidence_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article